Yurogen Biosystems Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Yurogen Biosystems's estimated annual revenue is currently $3.6M per year.(i)
  • Yurogen Biosystems's estimated revenue per employee is $155,000

Employee Data

  • Yurogen Biosystems has 23 Employees.(i)
  • Yurogen Biosystems grew their employee count by 5% last year.

Yurogen Biosystems's People

NameTitleEmail/Phone
1
Chief Scientific OfficerReveal Email/Phone
2
Director Antibody DiscoveryReveal Email/Phone
3
Senior Project ManagerReveal Email/Phone
4
Laboratory Operations ManagerReveal Email/Phone
5
Overseas Project Team ManagerReveal Email/Phone
6
研究助理Reveal Email/Phone
7
Research Assistant IIReveal Email/Phone
8
Research AssociateReveal Email/Phone
9
Research AssistantReveal Email/Phone
10
Research AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.7M82-45%$107.3MN/A
#2
$0.2M1-50%N/AN/A
#3
$6.2M4021%N/AN/A
#4
$42.2M2184%$165MN/A
#5
$14.6M94-37%$312.8MN/A
#6
$0.3M2-67%N/AN/A
#7
$235M366-5%$340.9MN/A
#8
$56M289-7%$7.6MN/A
#9
$4.7M6136%N/AN/A
#10
$2M138%N/AN/A
Add Company

What Is Yurogen Biosystems?

Yurogen Biosystems LLC is a private biotech company based in the Greater Boston area, a world-class biotech and biopharma hub. We are dedicated to produce premium antibodies and antibody-based products to meet broad needs of our clients. Along with our traditional polyclonal antibody production, Yurogen is commercializing an innovative platform that can efficiently develop monoclonal antibodies from a variety of host animals especially rabbit. Yurogen is developing a selection of antibodies that are widely used in in vitro diagnostics (IVD) as well as academic research. Our growing list of high quality antibodies are the reliable and cost-efficient tools that you can count on. Customized antibody services is offered at Yurogen to generate antibodies to meet the needs of our clients. Our state-of-the-art monoclonal antibody screening platform can significantly shorten the antibody screening process and yield high affinity monoclonal antibodies.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$3.6M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M23-52%N/A
#2
$4.7M23-18%N/A
#3
$4.7M23-4%N/A
#4
$4.3M2335%N/A
#5
$5.4M240%N/A